Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasm Metastasis

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

2,438 public trials 498 recruiting studies

Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Not Yet Recruiting

A Phase 1 First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid Tumors

NCT07583316

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +26 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Safety, Tolerability, and Preliminary Antitumor Activity of Non-Cationic Peptide-CD47 siRNA in Advanced Solid Tumors

NCT07583914

Conditions: Head and Neck Cancer, Head and Neck Neoplasms, Metastases, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

NCT07576725

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +119 more
Locations: Uganda Cancer Institute Kampala, Uganda

View Trial Details

Not Yet Recruiting

Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum

NCT07509008

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, Metastatic, +10 more
Locations: UT MD Anderson Houston, Texas, United States

View Trial Details

Not Yet Recruiting

NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies

NCT07563829

Conditions: Metastatic Malignant Neoplasm, Neoplasm Metastasis, Neoplasms, +3 more
Locations: University of California - San Diego La Jolla, California, United States

Johns Hopkins Baltimore, Maryland, United States

Montefiore The Bronx, New York, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

View Trial Details

Not Yet Recruiting

A Phase 2 Study of Luvometinib Combined With Anlotinib in KRAS-mutated NSCLC

NCT07562581

Conditions: KRAS-mutated, Metastasis, Neoplasm Metastasis, +6 more
Locations: Shanghai Chest Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET

NCT07285993

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Not Yet Recruiting

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer

NCT07374796

Conditions: Breast Cancer (Locally Advanced or Metastatic), Breast Cancer Screening, Breast Diseases, +11 more
Locations: University of Maryland Baltimore Washington Medical Center Glen Burnie, Maryland, United States

View Trial Details

Not Yet Recruiting

Prophylactic Radiotherapy to Prevent Bone Complications in Patients With Metastatic Solid Cancers

NCT07540650

Conditions: Bone Metastases, Metastatic Solid Tumor, Neoplasm Metastasis, +4 more
Locations: Institute of Oncology Ljubljana Ljubljana, Slovenia

View Trial Details

Not Yet Recruiting

Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver Cancer

NCT07537946

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details